在有癌症史和没有癌症史的受益人中比较医疗保险计划选择
Shelley A Jazowski1, Emma M Achola1, Lauren H Nicholas2
1Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN 37203, United States.
Health affairs scholar
|May 17, 2024
概括
患有癌症史的老年人更有可能选择具有补充覆盖的传统医疗保险. 这表明,由于过去的严重疾病经历,优先考虑强大的福利和财务保护.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 老年学是指老年学的学科.
- 卫生经济学 卫生经济学
背景情况:
- 医疗保险受益人面临着复杂的计划选择,带有不同的收益和成本.
- 目前尚不清楚老年人是否会在选择医疗保险计划时考虑过去的严重疾病.
研究的目的:
- 为了检查癌症史和初始医疗保险计划选择之间的关联.
- 了解以前的严重疾病是否影响医疗保险覆盖决策.
主要方法:
- 分析健康和退休研究数据从3811名参与者老龄化到医疗保险 (2008-2020年).
- 医疗保险优势与传统医疗保险的比较,基于癌症病史的补充保险选择.
主要成果:
- 有癌症史和没有癌症史的人中,相似比例的人选择了医疗保险优势.
- 患有癌症病史的人选择传统医疗保险加补充保险的可能性增加了8.03个百分点.
结论:
- 癌症史与选择传统医疗保险与补充福利的可能性更高.
- 这表明癌症幸存者可能会优先考虑提供更大的财务保护和强大的福利的计划.
- 需要加强教育资源,以帮助老年人选择合适的医疗保险计划.
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Nursing Ethical Principles II
956
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
956
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


